| Astonea Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar '2024 | Mar '2023 | Mar '2022 | |||
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 7.60 | 4.00 | 4.00 | ||
| Reserves | 4.37 | 4.16 | 3.49 | ||
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | ||
| Equity Application Money | 0.01 | 0.00 | 0.00 | ||
| Total Shareholders Funds | 11.98 | 8.16 | 7.49 | ||
| Secured Loans | 34.99 | 27.35 | 20.99 | ||
| Unsecured Loans | 7.40 | 8.64 | 8.54 | ||
| Total Debt | 42.39 | 35.99 | 29.53 | ||
| Other Liabilities | 0.30 | 0.13 | 0.07 | ||
| Total Liabilities | 54.67 | 44.28 | 37.09 | ||
| APPLICATION OF FUNDS : | |||||
| Gross Block | 36.35 | 31.23 | 28.38 | ||
| Less: Accumulated Depreciation | 14.43 | 10.49 | 6.99 | ||
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | ||
| Net Block | 21.92 | 20.74 | 21.39 | ||
| Lease Adjustments | 0.00 | 0.00 | 0.00 | ||
| Capital Work in Progress | 2.10 | 0.00 | 0.00 | ||
| Investments | 0.00 | 0.00 | 0.00 | ||
| Current Assets, Loans & Advances | |||||
| Inventories | 24.84 | 16.65 | 7.12 | ||
| Sundry Debtors | 25.43 | 19.08 | 19.31 | ||
| Cash and Bank Balance | 0.36 | 0.04 | 0.03 | ||
| Loans and Advances | 4.27 | 6.79 | 4.50 | ||
| Total Current Assets | 54.91 | 42.55 | 30.96 | ||
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 24.77 | 19.26 | 15.10 | ||
| Provisions | 1.28 | 0.24 | 0.06 | ||
| Total CL & Provisions | 26.05 | 19.50 | 15.17 | ||
| Net Current Assets | 28.86 | 23.05 | 15.79 | ||
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | ||
| Deferred Tax Assets | 0.00 | 0.00 | 0.00 | ||
| Deferred Tax Liability | 0.17 | 0.50 | 0.66 | ||
| Net Deferred Tax | -0.17 | -0.50 | -0.66 | ||
| Other Assets | 1.95 | 0.98 | 0.56 | ||
| Total Assets | 54.67 | 44.28 | 37.08 | ||
| Contingent Liabilities | 0.09 | 0.00 | 0.00 |